Product
BH002
1 clinical trial
1 indication
Indication
Solid TumoursClinical trial
Phase I Clinical Trial of Safety, Tolerability and Pharmacokinetics of BH002 in Patients With Advanced Solid TumorsStatus: Completed, Estimated PCD: 2023-03-10
1 clinical trial
1 indication